The reason for this dichotomy is unknown, but one possible explanation is that chemotherapy is able to alter the tumor cells and/or tumor microenvironment towards a more immunogenic state that could then be amplified by the presence of anti-PD-(L)1 antibodies [11]. The gene discussed is CD274; the disease is neoplasm.